Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2000

01-12-2000 | Paper Report

Does HCMV infection trigger the vascular damage in SSc?

Author: Oliver Distler

Published in: Arthritis Research & Therapy | Issue 1/2000

Login to get access

Excerpt

Systemic sclerosis (SSc) is a connective tissue disease characterized by vascular and immunological abnormalities. The aim of this study was to identify disease-relevant autoantigens. …
Literature
1.
Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A: Systemic sclerosis IgG autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med. 2000, 6: 1183-1186.CrossRef
Metadata
Title
Does HCMV infection trigger the vascular damage in SSc?
Author
Oliver Distler
Publication date
01-12-2000
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2000
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar-2000-66864

Other articles of this Issue 1/2000

Arthritis Research & Therapy 1/2000 Go to the issue

Paper Report

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

Paper Report

OPGL - the link between T cell activation and bone loss

Paper Report

CD28 augments phosphoinositide turnover

Paper Report

CD4+CD28+regulatory T cells in Sjogren's syndrome

Paper Report

T cell homeostasis in patients with rheumatoid arthritis

Paper Report

Bone anabolic effects of statins
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits